Osteopontin mediates acquired resistance to hypoxia-inducing antiangiogenics and promotes anti-PD-L1 refractoriness in breast cancer models. (jci.org)

Authors: Ruiz-Sepulveda JL … Quintela-Fandino M Journal: Journal of Clinical Investigation Published: 2026-07-15 DOI: https://doi.org/10.1172/JCI174092